Literature DB >> 34077740

Gold nanostructures as mediators of hyperthermia therapies in breast cancer.

Andreia Granja1, Marina Pinheiro1, Célia T Sousa2, Salette Reis3.   

Abstract

Breast cancer is the leading cause of cancer-related deaths among women. Due to the limitations of the current therapeutics, new treatment options are needed. Hyperthermia is a promising approach to improve breast cancer therapy, particularly when combined with chemo and radiotherapy. This area has gained more attention following association with nanotechnology, with the emergence of modalities, such as photothermal therapy (PTT). PTT is a simple, minimally invasive technique that requires a near infrared (NIR) light source and a PTT agent. Gold nanostructures are excellent PTT agents as they offer biocompatibility, versatility, high photothermal conversion efficiency, imaging contrast and an easily-modified surface. In this review, we describe the molecular basis and the current clinical aspects of hyperthermia-based therapies. The emergent area of nanoparticle-induced hyperthermia will be explored, in particular gold nanostructure-mediated PTT, focusing on recent preclinical studies for breast cancer management.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  Breast cancer; Gold nanoparticles; Multimodal therapy; NIR laser; Nanotechnology; Photothermal therapy

Year:  2021        PMID: 34077740     DOI: 10.1016/j.bcp.2021.114639

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  3 in total

Review 1.  Gold Nanorod-Assisted Photothermal Therapy and Improvement Strategies.

Authors:  Mitchell Lee Taylor; Raymond Edward Wilson; Kristopher Daniel Amrhein; Xiaohua Huang
Journal:  Bioengineering (Basel)       Date:  2022-05-05

2.  Chidamide stacked in magnetic polypyrrole nano-composites counter thermotolerance and metastasis for visualized cancer photothermal therapy.

Authors:  Sizhen Wang; Zhiqiang Ma; Zhang Shi; Ying Huang; Tianheng Chen; Lei Hou; Tao Jiang; Feng Yang
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

Review 3.  Hyperthermia combined with immune checkpoint inhibitor therapy in the treatment of primary and metastatic tumors.

Authors:  Ximing Yang; Miaozhi Gao; Runshi Xu; Yangyang Tao; Wang Luo; Binya Wang; Wenliang Zhong; Lan He; Yingchun He
Journal:  Front Immunol       Date:  2022-08-12       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.